Nine Trends that Will Determine the Future of Cancer Research in the World
Once you're logged in, please select the "register" tab to process your payment and complete your registration.
Once you register for the course, you will have 180 days (approximately 6 months) from the date of enrollment to complete the course. The exact date that your access expires will be indicated within the Course Summary box on this webpage.
Healthcare providers and researchers.
- Identify the nine key cancer trends that will have the greatest impact on the future of cancer around the world.
- Construct important research questions that must be answered to effectively respond to one or more of these trends.
- Identify the types of members of a research team that will be required to conduct population based research, including the application of tailored approaches to cancer treatment.
Richard Wender, MD
Chief Cancer Control Officer, American Cancer Society
Dr. Richard Wender is charged with providing oversight and guidance for the national and global cancer control programs of the American Cancer Society, including cancer screening, tobacco control, access to care, and quality of life, in addition to providing high level oversight for the Society's global cancer control efforts.
For 34 years, Dr. Wender worked as a family physician in the Department of Family and Community Medicine at Thomas Jefferson University in Philadelphia, Pa., serving as the Director of the Family Medicine Residency Program from 1985 - 1995. and Vice Chair from 1995 - 2002. From 2002 until his acceptance of his position at the Society, Dr. Wender was the Alumni Professor and Chair of the Department of Family and Community Medicine, a large, comprehensive department addressing the tripartite mission of educating future health care professionals, conducting public health and health services research, and improving care for all individuals living in the Philadelphia region through delivery of primary care services and partnership with many community based organizations. During Dr. Wender's tenure, the Department also began developing a global health program. The ultimate mission of the Department remains to improve health outcomes for all, with a particular focus on reducing health disparities. Dr. Wender has held numerous other administration positions at Jefferson, including serving as President and CEO of JeffCare, Thomas Jefferson University Hospital's physician-hospital organization and President and CEO of Jefferson Medical Care, a group of Hospital owned primary care and specialty practices.
Dr. Wender has led numerous initiatives designed to improve preventive care and chronic disease management, including being a pioneer in the Patient Centered Medical Home initiative. Much of this work has focused on cancer prevention and control. He has served as an author of numerous scholarly works including co-authoring several cancer screening guidelines. He is the first author on the recent American Cancer Society lung cancer screening guideline. Dr. Wender currently serves as chair of the National Colorectal Cancer Roundtable, an organization consisting of nearly 80 organizations dedicated to eliminating colon cancer as a major public health problem.
Dr. Wender has received numerous awards and honors, including the Laurel for Cancer Prevention Leadership from the Prevent Cancer Foundation and the St. George Medal from the American Cancer Society. In 2006, Dr. Wender was elected as the national President of the American Cancer Society, becoming the first primary care physician to serve in this capacity. While his new position will allow him to have a greater impact on the cancer burden around the world, his roots remain grounded in primary care, and he continues to provide primary care to patients at Jefferson. Through advocacy and through constructing lasting partnerships, Dr. Wender remains committed to building bridges between public health, community medicine, and primary care
Relevant to the content of this CME activity, Dr. Wender has no conflict of interests to disclose.
Copyright: All rights reserved. By viewing this activity, participants agree to abide by copyright and trademark laws, intellectual property rights, and all other applicable laws of the United States of America. No part of the syllabus may be used or reproduced in any manner whatsoever without written permission, except in the case of brief quotations embodied in articles or reviews.
Internet CME Policy: The Office of Continuing Medical Education (CME) at Des Moines University (DMU) is committed to protecting the privacy of its customers. DMU CME maintains its Internet site as an information resource and service for health professionals. DMU CME will keep your personal and credit information confidential when you participate in an Internet based program. Your information will never be given to anyone outside of the DMU CME program. DMU CME collects only the information necessary to provide you with the services that you request.
Continuing Education Credit
- DO: Des Moines University is accredited by the American Osteopathic Association (AOA) and approves this enduring materials activity for 1.0 AOA Category 2-B credit(s).
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Nurse: Des Moines University continuing education is Iowa Board of Nursing approved provider #112. This enduring materials activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit awarded.
- Other: This enduring materials activity is designated for 1.0 AMA PRA Category 1 Credit(s)™.
No commercial interest provided financial support for this continuing education activity.
- 1.00 AOA Category 2B
- 1.00 AMA PRA Category 1 Credits™
- 1.00 IBON
- 1.00 CE Contact Hour(s)